OC
LAB icon

Oppenheimer & Co’s Standard BioTools LAB Stock Holding History

Oppenheimer & Co’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$323K Buy
350,890
+231,140
+193% +$280K ﹤0.01% 1358
2025
Q4 		$153K Buy
119,750
+33,150
+38% +$44.5K ﹤0.01% 1470
2025
Q3 		$113K Hold
86,600
– – ﹤0.01% 1605
2025
Q2 		$104K Hold
86,600
– – ﹤0.01% 1561
2025
Q1 		$93.5K Buy
+86,600
New +$122K ﹤0.01% 1521

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Oppenheimer & Co's LAB Position: Q1 2026 in Review

Oppenheimer & Co increased its Standard BioTools (LAB) stake by 193% in Q1 2026, buying an estimated $280K and bringing the position to 350,890 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Oppenheimer & Co first reported a position in LAB in Q1 2025 and has held it in 5 quarters since. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Oppenheimer & Co held 350,890 shares of Standard BioTools worth $323K as of Q1 2026.
  • Oppenheimer & Co bought 231,140 Standard BioTools shares in Q1 2026, an estimated $280K.
  • Standard BioTools made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1358 holding.
  • Oppenheimer & Co first reported a position in Standard BioTools in Q1 2025 and has held it in 5 quarters since.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.